Loading insider details...
Beta
Latest Form 4 (Jul 2, 2026): Grant/Award of 3,553 ALMS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | ALUMIS INC. (ALMS) | Grant/Award | 3,553 | n/a |
| Feb 5, 2026 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 550,000 | n/a |
| Aug 1, 2025 | ALUMIS INC. (ALMS) | Grant/Award | 49,800 | n/a |
| Feb 14, 2025 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 380,000 | n/a |
| Jul 1, 2024 | ALUMIS INC. (ALMS) | Disposition to Issuer | 23,529 | n/a |
| Jul 7, 2023 | NexImmune, Inc. (NEXI) | Grant/Award | 44,983 | n/a |
| Apr 6, 2023 | NexImmune, Inc. (NEXI) | Disposition to Issuer | 61,678 | n/a |
| Jun 15, 2022 | NexImmune, Inc. (NEXI) | Grant/Award | 61,678 | n/a |
| Feb 16, 2021 | NexImmune, Inc. (NEXI) | Grant/Award | 9,556 | n/a |